Advancing the Science of Cartilage Repair.
Zimmer Biomet’s OCA Kit contains fresh young allograft cartilage and cancellous chips. It is intended to provide surgeons with an early-intervention option to treat osteochondral defects and restore articular cartilage for multiple applications.
Procedures
- Cartilage Repair
Philosophies
- Early Intervention
Application
- Multiple
Zimmer Biomet fresh young allograft cartilage can significantly reduce pain and improve function for at least 5 years1,2
Survivorship at 5 years
85%in knees.1 |
Survivorship at 5 years
89%in knees.3 |
|---|
Product Features
The OCA Kit cartilage graft consists of young living articular cartilage, which contains 10x greater chondrocyte density than adult tissue and does not elicit an allogeneic immune response 4-6*
The modular graft makes it possible to address deficiencies of various sizes and shapes.
Specifications
Reimbursement
For any inquiries regarding reimbursement, please contact Zimmer Biomet Reimbursement Hotline: Phone: 1-866-946-0444. Hotline Hours: Monday-Friday, 8am- 5pm, EST
Email: [email protected]
Benefits
Single-stage Procedure
- Allows for a single-stage procedure with fibrin fixation, eliminating the need for harvesting autograft or a periosteal flap – thereby reducing donor site morbidity and saving time in the OR
Fresh Young Allograft Cartilage Advantage
- Juvenile allograft cartilage contains 10x greater chondrocyte density than adult tissue and does not elicit an allogeneic immune response4-6*
High Five Year Survivership1,3
- Zimmer Biomet Longitudinal Data Collection (LDC) on fresh young allograft cartilage show survivorship at 5 years 85% in knee and 89% in ankle1,3
Additional Information
References
- Data on file Zimmer Biomet. Post-Market, Longitudinal Data Collection Study of DeNovo® NT for Articular Cartilage Defects of the Knee, protocol number CSU2010-22B.
- Farr, J., et al. Clinical, Radiographic and Histological Outcomes following Cartilage Repair with Particulated Juvenile Articular Cartilage: A 2-Year Prospective Study. American Journal of Sports Medicine. 42(6):1417-25, 2014.
- Data on file Zimmer Biomet. Post-Market, Longitudinal Data Collection Study of Articular Cartilage Lesions in the Ankle Treated with DeNovo NT Natural Tissue Graft, protocol number CSU2010-21B. Nov 13, 2017.
- Adkisson, H. D., et al. The potential of human allogenic juvenile chondrocytes for restoration of articular cartilage. American Journal of Sports Medicine. 38(7):1324-33, 2010.
- Federer, J., et al. The Promise of Chondral Repair Using Neocartilage. In Sandell, J. S., et al (red) Tissue Engineering in Musculoskeletal Clinical Practice. American Academy of Ortopaedic Surgeons. Chapter 22, pp. 219-226, 2004.
- Adkisson, H. D., et al. Immune evasion by neocartilage-derived chondrocytes: Implications for biologic repair of joint articular cartilage. Stem Cell Research. 4:57-68, 2010.
- Farr, J., et al. Chondral Defect Repair with Particulated Juvenile Cartilage Allograft. Cartilage. Oct 2(4):346-353, 2011.
- Coetzee, J. C., et al. Treatment of Osteochondral Lesions of the Talus With Particulated Juvenile Cartilage. Foot & Ankle International. Sep;34(9):1205-11, 2013.
*Cell assays are not necessarily indicative of clinical performance
Legal Manufacturer
Zimmer, Inc.
1800 West Center Street
Warsaw, Indiana 46580 USA
Related Products
Biologics
Leading the industry in providing quality, consistent and replicatable autologous products and solutions for a variety of biological needs.
ASC Solutions
Whether you’re looking to open a new facility, add a service line or enhance efficiencies, we have options to help address the most common clinical and economical challenges you face in an Ambulatory Surgery Center.
LINKS
CALL US
The name “Paragon 28” was chosen by design — to never lose focus on our goal to advance the science of foot and ankle surgery.
© 2025 Paragon 28, Inc.